LISANTI CAPITAL GROWTH, LLC – BioCryst Pharmaceuticals, Inc. Transaction History
LISANTI CAPITAL GROWTH, LLC portfolio value:
$3.84M
portfolio value
BioCryst Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | 0.00% | 305.09K shares | 3.84M | $12.6 | 305.09K |
Q2 2022 | share | Decrease | -100.00% | -662.64K shares | -10.77M | $10.58 | 0 |
Q1 2022 | share | Increase | 0.00% | 662.64K shares | 10.77M | $16.26 | 662.64K |
Q4 2021 | share | Decrease | -100.00% | -219.45K shares | -3.15M | $13.79 | 0 |
Q3 2021 | share | Decrease | -35.87% | -122.73K shares | -2.25M | $14.37 | 219.45K |
Q2 2021 | share | Decrease | -27.58% | -130.33K shares | 604K | $15.81 | 342.18K |
Q1 2021 | share | Increase | 0.00% | 472.52K shares | 4.80M | $10.17 | 472.52K |
Q2 2019 | share | Decrease | -100.00% | -221.56K shares | -1.80M | $3.79 | 0 |
Q1 2019 | share | Increase | 0.00% | 221.56K shares | 1.80M | $8.14 | 221.56K |